Browse studies, page 20
Page 20 of 1,159, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- 1636: The Efficacy and Safety of Tadalafil Administered Once a Day for Lower Urinary Tract Symptoms (LUTS) in Men with Benign Prostatic Hyperplasia (BPH) The Journal of Urology, 2006
- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, 5-Group, Multinational Study to Evaluate the Efficacy, Dose Response, and Safety of Tadalafil Once-a-Day Dosing for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia ClinicalTrials.gov · COMPLETED, 2008
- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Pilot Study to Evaluate the Efficacy and Safety of Tadalafil and Tamsulosin Once-a-Day Dosing for 12 Weeks in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia ClinicalTrials.gov · COMPLETED, 2008
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Study to Evaluate the Safety and Efficacy of Daily Tadalafil for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia on Concomitant Alpha1-Adrenergic Blocker Therapy ClinicalTrials.gov · COMPLETED, 2009
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Study to Evaluate the Efficacy and Safety of Tadalafil Once-a-day Dosing for 12 Weeks in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia ClinicalTrials.gov · COMPLETED, 2012
- Double-blind, Placebo-controlled Study on Men With Lower Urinary Tract Symptoms to Assess Changes in Pressure Flow Study and in Molecular Profile of Prostatic Tissue After 12 Weeks Treatment With Tadalafil ClinicalTrials.gov · COMPLETED, 2020
- A Phase 3b, Randomized, Double-blind, Placebo-controlled Parallel-design Study to Evaluate the Efficacy and Safety of Tadalafil Co-administered With Finasteride for 6 Months in Men With Lower Urinary Tract Symptoms and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia ClinicalTrials.gov · COMPLETED, 2012
- Tadalafil once daily in the treatment of lower urinary tract symptoms ( LUTS ) suggestive of benign prostatic hyperplasia ( BPH ) in men without erectile dysfunction BJU International, 2013
- 956: Efficacy of Tadalafil Dosed Once a Day to Treat Erectile Dysfunction in Men with Comorbid Moderate or Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia The Journal of Urology, 2007
- 1370 safety and efficacy of tadalafil 5MG dosed once daily in patients on α-blocker therapy for benign prostatic hyperplasia accompanied by erectile dysfunction The Journal of Urology, 2010
- 1973 a multicenter, placebo-controlled trial investigating the safety and efficacy of once daily tadalafil in MEN with signs and symptoms of benign prostatic hyperplasia taking concomitant A1-adrenergic antagonist therapy The Journal of Urology, 2011
- Evaluation of efficacy of PDE5 inhibiter by penile blood pressure for benign prostatic hyperplasia patients with lower urinary tract symptoms: MP09‐07 The Journal of Urology, 2017
- Effect of tadalafil that was additionally administered to patients receiving an ALPHA1-blocker in japanese MEN with lower urinary tract symptoms suggestive of benign prostatic hyperplasia Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2016
- PD24-01 double blind, randomized, placebo controlled study of tadalafil with dutasteride versus tadalafil with placebo for lower urinary tracts symptoms secondary to benign prostatic hyperplasia: a single centre study Journal of Urology, 2019
- Evaluating the effects of switching from dutasteride to tadalafil in benign prostatic hyperplasia patients with lower urinary tract symptoms: A randomized, open‐label, multicenter study International journal of urology, 2019
- Editorial Comment from Dr Amano to Tadalafil is sufficiently effective for severe chronic prostatitis/chronic pelvic pain syndrome in patients with benign prostatic hyperplasia International journal of urology, 2020
- Editorial Comment from Dr Tanaka to Tadalafil is sufficiently effective for severe chronic prostatitis/chronic pelvic pain syndrome in patients with benign prostatic hyperplasia International journal of urology, 2020
- 028 Efficacy and Safety of Fixed Dose Combination of Tamsulosin and Tadalafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction The Journal of Sexual Medicine, 2017
- Efficacy and safety of fixed dose combination of tamsulosin and tadalafil in patients with benign prostatic hyperplasia and erectile dysfunction: PD69‐05 The Journal of Urology, 2017
- Prospective Comparative Study between Silodosin 8 mg Versus Combination of Tadalafil 5mg and Silodosin 4mgfor treatment of Lower Urinary Tract Symptoms related to Benign Prostatic Hyperplasia SVU-International Journal of Medical Sciences, 2021
- Tadalafil versus tadalafil with sildosin in the management of symptomatic benign prostatic hyperplasia Menoufia Medical Journal, 2022
- Re: Efficacy and Safety of Tadalafil 5 mg Once Daily in the Treatment of Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia in Men Aged ≥75 Years: Integrated Analyses of Pooled Data from Multinational, Randomized, Placebo-Controlled Clinical Studies Journal of Urology, 2018
- Alfuzosin monotherapy versus alfuzosin plus tadalafil combination in young males with lower urinary tract symptoms secondary to benign prostatic hyperplasia Asian Journal of Pharmaceutical and Clinical Research, 2026
- The Effect of Tadalafil 5 mg on Outflow Obstruction due to Benign Prostatic Hyperplasia The Quarterly journal of medicine, 2024
- The use of tadalafil in the treatment of lower urinary tract symptoms among men suffering from benign prostatic hyperplasia, on the example of the population of the Greater Poland province Biuletyn Głównej Biblioteki Lekarskiej, 2024
- Comparative assessment of efficacy of tadalafil and tamsulosin alone and in combination among MEN with benign prostatic hyperplasia International Journal of Medical and Biomedical Studies, 2021
- COMPARING The EFFICACY AND SAFETY OF TREATMENT WITH FIXED DOSE OF TADALAFIL OR TAMSULOSIN AND THEIR COMBINATION THERAPY IN Patients With BENIGN PROSTATIC HYPERPLASIA and Erectile Dysfunction The Quarterly journal of medicine, 2021
- Safety and Efficacy of Silodosin versus Tadalafil in Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptoms; A prospective comparative study Fayoum University Medical journal, 2023
- Safety and Effectiveness of Vibegron in Japanese Patients With Overactive Bladder: A Japanese Postmarketing Survey Lower urinary tract symptoms, 2024
- Trends in experimental autoimmune prostatitis: insights into pathogenesis, therapeutic strategies, and redefinition American journal of clinical and experimental urology, 2024
- Two cases of pelvic hematoma after prostatic urethral lift surgery IJU case reports, 2024
- Acute dual therapeutic effects of the BKCa channel opener LDD175 on erectile dysfunction and lower urinary tract symptoms in chronic pelvic ischemia: a preliminary study Asian journal of andrology, 2025
- Efficacy of combination therapy tadalafil plus tamsulosin in ureteral stents-related symptoms relief Central European journal of urology, 2024
- Enhancing medication appropriateness: Insights from the STOPP (Screening Tool of Older Persons' Prescriptions) criteria version 3 on prescribing practices among the older adults in Pakistan Frontiers in pharmacology, 2025
- Postoperative pain management after ureteroscopy: focused approaches to reducing opiate dependence Pain management, 2025
- Association Between Baseline Neutrophil-to-Lymphocyte Ratio and Short-Term Urinary Quality of Life During BCG Induction in Male Patients with Non-Muscle-Invasive Bladder Cancer: A Prospective Observational Study Journal of clinical medicine, 2025
- Ixeris polycephala Extract Alleviates Progression of Benign Prostatic Hyperplasia via Modification of Proliferation, Apoptosis, and Inflammation Pharmaceuticals (Basel, Switzerland), 2024
- Smooth muscle contractility of laser-enucleated prostate tissues and impacts of preoperative α1-blocker treatment in patients with and without catheterization Scientific reports, 2025
- Erectile Dysfunction: Expert Panel Recommendations for Evaluation and Management in the United Arab Emirates Journal of multidisciplinary healthcare, 2025
- Nanotechnology for reproductive healthcare: a comprehensive review Journal of nanobiotechnology, 2026
- How Would You Manage This Patient With Benign Prostatic Hyperplasia? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center Annals of internal medicine, 2023
- Efficacy and safety of dutasteride with tadalafil add-on therapy in Japanese men with lower urinary tract symptoms secondary to benign prostatic hyperplasia Research Square, 2022
- Health-Care Resource Utilization and Treatment Patterns in Men with Erectile Dysfunction and Benign Prostatic Hyperplasia-Associated Lower Urinary Tract Symptoms in the United States: A Retrospective Database Study Patient preference and adherence, 2023
- Holmium laser enucleation of the prostate as a secondary surgery following prostatic urethral lift IJU case reports, 2024
- A Brief Overview of Cholinergic and Phosphodiesterase-5 Inhibitors in Diabetic Bladder Dysfunction International journal of molecular sciences, 2024
- Management of prolonged post-operative pelvic pain after transurethral prostate surgery: a clinical real-world survey and international comparison of therapy regimens BMC urology, 2025
- Phytomedicines in Pharmacotherapy of LUTS/BPH - What Do Patients Think? Patient preference and adherence, 2024
- Robot-assisted radical prostatectomy in a patient with Zinner syndrome International journal of surgery case reports, 2025
- Prostate Size and Its Effect on Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Improvement After Convective Water Vapor Thermal Therapy The Journal of urology, 2025
- Japan's Perspective on Facilitating Drug Development Through Asian Cooperation in Multi-Regional Clinical Trials: Insights From Regulatory Research Clinical and translational science, 2025
- Water Vapor Energy Therapy Safely Reduces Urinary Medication Use: A Multicenter Retrospective Real-World Study in Japan (SCCOP Study 24-01) International journal of urology : official journal of the Japanese Urological Association, 2025
- Protective and Antioxidant Effects of Quercetin Loaded Black Cumin (Nigella sativa L) Seed Oil-Based Nanoemulsion in Testosterone-Induced Benign Prostatic Hyperplasia: An Experimental Study Archives of Razi Institute, 2024
- Benign Prostatic Hyperplasia and Sexual Dysfunction: Review of the Impact of New Medical and Surgical Therapies on Sexual Health Current urology reports, 2025
- Vardenafil and Tamsulosin in the Management of Ureteral Stent-Related Symptoms: A Prospective Comparative Study Urology research & practice, 2025
- Chronic inflammation in benign prostatic hyperplasia: Pathophysiology and treatment options International journal of urology : official journal of the Japanese Urological Association, 2024
- Comparison of Durability Between Rezum Water Vapor Therapy and UroLift in Treating Benign Prostatic Hyperplasia: A Multicenter Propensity Score-Matched Analysis Cureus, 2025
- Voiding symptoms aggravate with decreasing stromal/epithelial ratio and increasing glandular-epithelial content in patients undergoing laser enucleation for benign prostatic hyperplasia, independently from prostate size PloS one, 2026
- Efficacy and Safety of Xialiqi for the Treatment of Benign Prostatic Hyperplasia in a Randomized Trial European urology open science, 2025
- Do patients Rezum medications?-a real-world analysis of medical retreatment after water vapor thermal therapy Translational andrology and urology, 2025
- Isosorbide dinitrate as an effective adjunct therapy for acute urinary retention: A randomized controlled trial BJUI compass, 2026
- Transperineal Laser Ablation of Symptomatic Benign Prostatic Hyperplasia With Median-Lobe Enlargement: A Single-Center Experience Lasers in surgery and medicine, 2026
- Tadalafil enhances the inhibitory effects of tamsulosin on neurogenic contractions of human prostate and bladder neck The journal of sexual medicine, 2012
- Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia in men with or without erectile dysfunction Urology, 2010
- Comparative efficacy assessment of tamsulosin vs. tamsulosin plus tadalafil in the treatment of LUTS/BPH. Pilot study The journal of sexual medicine, 2008
- Phosphodiesterase type 5 inhibitors for the treatment of male lower urinary tract symptoms Reviews in urology, 2007
- Erratum: Efficacy of tamsulosin and tadalafil in relieving benign prostatic hyperplasia related symptoms: A randomized double blind placebo controlled cross-over study Indian journal of urology : IJU : journal of the Urological Society of India, 2019
- A randomized controlled study of the efficacy of tadalafil monotherapy versus combination of tadalafil and mirabegron for the treatment of persistent overactive bladder symptoms in men presenting with lower urinary tract symptoms (CONTACT Study) Neurourology and urodynamics, 2020
- Tadalafil 5 mg once daily is a rationale option for simultaneous treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction Urologiia (Moscow, Russia : 1999), 2019
- Efficacy and safety of tadalafil 5 mg once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: subgroup analyses of pooled data from 4 multinational, randomized, placebo-controlled clinical studies Urology, 2013
- Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in Asian men International journal of urology : official journal of the Japanese Urological Association, 2013
- Trends in drug treatment of benign prostatic hyperplasia in Japan based on the National Database Open Data International journal of urology : official journal of the Japanese Urological Association, 2024
- Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and Finasteride Journal of personalized medicine, 2023
- Pharmacological treatment of benign prostatic hyperplasia Der Urologe. Ausg. A, 2016
- Soluble Guanylate Cyclase Activators to Treat Benign Prostatic Hyperplasia and associated LUTS. Continence (Amsterdam, Netherlands), 2023
- Inhibition of Adrenergic and Non-Adrenergic Smooth Muscle Contraction in the Human Prostate by the Phosphodiesterase 10-Selective Inhibitor TC-E 5005 The Prostate, 2016
- The Efficacy and Safety of Tadalafil 5 mg Once Daily in Korean Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: An Integrated Analysis The world journal of men's health, 2014
- Cyclic nucleotide metabolism including nitric oxide and phosphodiesterase-related targets in the lower urinary tract Handbook of experimental pharmacology, 2011
- Safety and efficacy of the combination of once-daily tadalafil and alpha-1 blocker in Japanese men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A randomized, placebo-controlled, cross-over study International journal of urology : official journal of the Japanese Urological Association, 2017
- Efficacy and safety of tadalafil 5 mg once daily in the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in men aged ≥75 years: integrated analyses of pooled data from multinational, randomized, placebo-controlled clinical studies BJU international, 2017
- Role of phosphodiesterase type 5 inhibitors for lower urinary tract symptoms The Annals of pharmacotherapy, 2013
- Phosphodiesterase-5 inhibitors and benign prostatic hyperplasia Current opinion in urology, 2010
- Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review Cureus, 2023
- The role of combination medical therapy in benign prostatic hyperplasia International journal of impotence research, 2008
- Phosphodiesterase (PDE) inhibitors in the treatment of lower urinary tract dysfunction British journal of clinical pharmacology, 2011
- Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia Therapeutic advances in urology, 2016
- A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction Therapeutic advances in urology, 2014
- Medical Advancements in Benign Prostatic Hyperplasia Treatments Current urology reports, 2024
- Therapeutic Targeting of miR-21 Restores SASH1 and Sensitizes HBV-HCC to Sorafenib Cancers, 2026
- Diacerein improves liver fibrosis, steatosis, and atherosclerosis in ApoE knockout mice Journal of molecular medicine, 2026
- A novel cell-penetrating peptide supports hair follicle growth through anti-inflammatory and growth factor–associated mechanisms in preclinical models BMC Biotechnology, 2026
- Osteogenic potential of adult stem cells from human maxillary sinus membrane by Simvastatin in vitro: preliminary report Journal of the Korean Association of Oral and Maxillofacial Surgeons, 2013
- Pharmacological Evaluation of Araliadiol as a Novel Anti-Inflammatory Agent in LPS-Induced RAW 264.7 Cells Biomedicines, 2025
- Synergistic attenuation of complete freund’s adjuvant-induced inflammation in mice using shinbaro-pelubiprofen: a novel therapeutic complex Molecular Medicine, 2025
- YN1548: A Novel Small-molecule Agonist of Human Glucagon-like Peptide-1 Receptor for the Treatment of Type 2 Diabetes Mellitus and Obesity European Journal of Pharmacology, 2025
- A novel carboxamide bromodomain inhibitor attenuates osteoarthritis via epigenetic repression of NF-κB and MAPK signaling Frontiers in Immunology, 2025
- Mitigation of radiation-induced esophageal fibrosis by macrophage-targeted phosphatidylserine-containing liposomes with partial PEGylation Bioactive Materials, 2025
- Synergistic Anti-Obesity Effects of Lactiplantibacillus plantarum Q180 and Phaeodactylum tricornutum (CKDB-322) in High-Fat-Diet-Induced Obese Mice International Journal of Molecular Sciences, 2025
- Macrophage targeting precision nanomedicine utilizing ROS-responsive metallozyme-loaded nanomicelle for enhanced treatment of gout-induced inflammation Science and Technology of Advanced Materials, 2025
- Enhancement of exfoliating efficacy of L-carnitine with ion-pair method monitored by nuclear magnetic resonance spectroscopy Scientific Reports, 2019
- Therapeutic potential of BOLD-100, a GRP78 inhibitor, enhanced by ATR inhibition in pancreatic ductal adenocarcinoma Cell Communication and Signaling, 2025
